Harbin Honor Pharmaceutical Co., Ltd.
Securities Code: 002437 Securities Abbreviation: Honor Pharmaceutical Announcement No.: 2026-039
Harbin Honor Pharmaceutical Co., Ltd. 2025 Annual General Meeting Resolution Announcement
The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Special Notes:
- No proposals were rejected at this general meeting.
- This general meeting does not involve any changes to resolutions previously passed by shareholders.
I. Meeting Convening and Attendance
- Time of on-site meeting: May 18, 2026, 15:00;
- Location of on-site meeting: First Floor Meeting Room, Building 28, Ronghui Garden, Yuhua Road, Airport Development Zone B, Shunyi District, Beijing;
- Meeting method: All shareholders voted on-site and via the internet.
- Convener: The Company's Board of Directors;
- Presiding Officer: Ms. Shen Zhenyu, Chairperson;
- Share registration date: May 11, 2026;
- Attendance:
| Attendance Method | Number of Shareholders | Number of Shares | Proportion of Voting Shares |
|---|---|---|---|
| On-site Attendance | 0 | 0 | 0% |
| Online Attendance | 433 | 337,829,544 | 15.1502% |
| Total | 433 | 337,829,544 | 15.1502% |
Of which: The number of small and medium investors attending this meeting was 424, representing 60,333,269 shares with voting rights, accounting for 2.7057% of the Company's total share capital.
- Some directors and senior management personnel attended/were present at this meeting. The convening of this general meeting complies with the Company Law, the Listing Rules of the Shenzhen Stock Exchange, and the Company's Articles of Association. Lawyers Longhai Wang and Hongquan Fang from Beijing Jingxuan Law Firm attended this general meeting for witnessing and issued a legal opinion.